Patents by Inventor Qun Wang

Qun Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220303324
    Abstract: The disclosure can provide a method for multi-service processing. The method includes: obtaining a target identifier of a target live streaming room; querying task data of a current task corresponding to the target live streaming room based on the target identifier; monitoring a task state of the current task in response to the queried task data; determining a first service identifier of a first service corresponding to a current time point based on preset service mapping information in response to the monitored task state being a task-ended state, the preset service mapping information representing mapping relationship between multiple services and preset service running durations; and sending task prompt information corresponding to the first service to a terminal corresponding to the target live streaming room based on the first service identifier, to make the terminal display the task prompt information in the target live streaming room.
    Type: Application
    Filed: October 29, 2021
    Publication date: September 22, 2022
    Inventors: Haowen ZHANG, Peiqiang TAN, Weibo LI, Qun WANG
  • Patent number: 11447542
    Abstract: The present disclosure provides binding proteins (e.g., antibodies or antigen binding fragments thereof) that specifically bind to Klebsiella pneumoniae O2 and induce opsonophagocytic killing of Klebsiella (e.g., Klebsiella pneumoniae) and/or protects mice from a lethal Klebsiella challenge. The present disclosure also provides methods of reducing Klebsiella (e.g., Klebsiella pneumoniae) or treating or preventing Klebsiella (e.g., Klebsiella pneumoniae) infection in a subject comprising administering the Klebsiella pneumoniae O2 binding proteins, (e.g., antibodies or antigen-binding fragments thereof) to the subject.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: September 20, 2022
    Assignees: MEDIMMUNE, LLC, HUMABS BIOMED SA
    Inventors: Qun Wang, Charles K. Stover, Meghan Pennini, Xiaodong Xiao, Davide Corti, Elisabetta Cameroni, Martina Beltramello, Gilad Kaplan, Anna DeMarco
  • Publication number: 20220233734
    Abstract: Disclosed are a disinfection and sterilization apparatus and method for a refrigerated container transportation system.
    Type: Application
    Filed: January 28, 2022
    Publication date: July 28, 2022
    Inventors: Gengyu CAO, Changhao WANG, Qun WANG
  • Publication number: 20220209878
    Abstract: Disclosed are a method, system and device for pushing information, and storage medium thereof. The method includes: receiving an information pushing request transmitted by a service end; then obtaining the online state information of a live broadcast room on the basis of identification information carried in the information pushing request, and according to the online state information, determining a signaling server set; and pushing information content to each signaling server in the signaling server set, and by means of each signaling server, pushing the information content to each client connected to the live broadcast room.
    Type: Application
    Filed: March 18, 2022
    Publication date: June 30, 2022
    Inventors: Gang LI, Yong DUAN, Qun WANG
  • Patent number: 11320440
    Abstract: The application of PDCD4 as a drug treatment target for anti-depression and/or anti-anxiety disorders has been proved by experimental research that the increase of PDCD4 is an important factor leading to depression in the process of stress; PDCD4 as a target to inhibit its expression or function can play a good antidepressant role, and has no effect on normal physiological state. Therefore, PDCD4 can be used as a target in the preparation and screening of antidepressant and/or anxiolytic drugs, which has a broad application prospect.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: May 3, 2022
    Assignee: SHANDONG UNIVERSITY
    Inventors: Lining Zhang, Yuan Li, Qun Wang, Chun Guo, Faliang Zhu
  • Publication number: 20220107776
    Abstract: A screen transmission processing method and device. The method includes determining that a source device is connected to a screen transmission device, wherein the screen transmission device is configured to be in a communication connection with a target device with which a pairing is completed; determining that a screen transmission client has been installed in the source device; determining that the screen transmission client is in a state to be updated; in response to the state to be updated, acquiring an update file of the screen transmission client from the target device through the screen transmission device; and according to the update file, updating the screen transmission client.
    Type: Application
    Filed: December 14, 2021
    Publication date: April 7, 2022
    Applicants: GUANGZHOU SHIYUAN ELECTRONIC TECHNOLOGY COMPANY LIMITED, GUANGZHOU SHIZHEN INFORMATION TECHNOLOGY CO., LTD.
    Inventors: Jiaye YANG, Nan TIAN, Zhiqiang XIAO, Yingyan XIN, Qun WANG, Yichang GU
  • Publication number: 20220089987
    Abstract: This disclosure includes regenerated inorganic fermented beverage stabilization and/or clarification media and a process for such regeneration. Inorganic stabilization and clarification media (for processing beer or the like) may include expanded perlite or other expanded natural glasses, diatomaceous earth, silica gel or other precipitated silicas and compositions that incorporate these materials. Such media may be regenerated individually, together in a mixture or together as part of a composite product.
    Type: Application
    Filed: November 30, 2021
    Publication date: March 24, 2022
    Applicant: EP Minerals, LLC
    Inventors: Scott K. Palm, Qun Wang
  • Publication number: 20220056113
    Abstract: The present disclosure provides binding proteins (e.g., antibodies or antigen binding fragments thereof) that specifically bind to Klebsiella pneumoniae O1 and induce opsonophagocytic killing of Klebsiella (e.g., Klebsiella pneumoniae). The present disclosure also provides methods of reducing Klebsiella (e.g., Klebsiella pneumoniae) or treating or preventing Klebsiella (e.g., Klebsiella pneumoniae) infection in a subject comprising administering the Klebsiella pneumoniae O1 binding proteins, (e.g., antibodies or antigen-binding fragments thereof) to the subject.
    Type: Application
    Filed: August 9, 2021
    Publication date: February 24, 2022
    Inventors: Qun WANG, Charles K. STOVER, Meghan PENNINI, Chew-shun CHANG, Xiaodong XIAO, Jamese HILLIARD, Gilad KAPLAN, Davide CORTI, Elisabetta CAMERONI, Martina BELTRAMELLO
  • Patent number: 11243177
    Abstract: A diatomite product and method of using such is disclosed. The diatomite product may comprise sodium flux-calcined diatomite, wherein the diatomite product has a crystalline silica content of less than about 1 wt %, and the diatomite product has a permeability between 0.8 darcy and about 30 darcy. In some embodiments, the diatomite product may be in particulate or powdered form. This disclosure also concerns flux-calcined silica products containing low or non-detectable levels of crystalline silica. Some of these products can be further characterized by high permeabilities and a measurable content of opal-C, a hydrated form of silicon dioxide.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: February 8, 2022
    Assignee: EP MINERALS, LLC
    Inventors: Peter E. Lenz, Scott K. Palm, George A. Nyamekye, Bradley S. Humphreys, Qun Wang
  • Publication number: 20210379550
    Abstract: A water injection method for a PID control-based adaptive intelligent water injection system is provided. The system includes a water injection portion, a power portion, a control portion, and a measurement and transmission portion. The water injection portion includes a hydrogenation reactor, heat exchangers, air coolers, and a separation tank. The power portion includes a motor and a water pump. The control portion includes a console and a bus. Temperature, pressure and flow velocity transmitters are additionally arranged at each of inlet and outlet pipes of various heat exchangers, and water injection points are disposed. Temperature, pressure and flow velocity signals of the inlet and outlet pipes of heat exchange devices are monitored, and the console performs error analysis on the three signals and uses a PID control algorithm to control the adjustment valve to alter the valve opening degree to adjust the water injection amount in real time.
    Type: Application
    Filed: April 20, 2020
    Publication date: December 9, 2021
    Applicant: ZHEJIANG SCI-TECH UNIVERSITY
    Inventors: Haozhe JIN, Guofu OU, Zhichao FAN, Yong GU, Qun WANG, Chao WANG
  • Publication number: 20210340756
    Abstract: The present invention discloses a construction method of 3D printing and weaving integrated building, comprising: selecting basic building structural components, using finite element analysis after spatial modeling, and combining stress nephogram to set a discrimination domain value and optimize a structure space, obtaining a structural component skeleton; calculating and analyzing the structural component skeleton, determining a weaving range and weaving density of a wire according to weak areas and sizes under structural stress; and then determining a printing process and weaving process according to the structural component skeleton, the weaving range and the weaving density; preparing 3D printing material; 3D printing a matrix and weaving the wire according to the printing process and weaving process, constructing layer by layer, or printing segments, and then connecting segments by preset tenoning structural sections to form a 3D printing and weaving integrated building.
    Type: Application
    Filed: September 4, 2019
    Publication date: November 4, 2021
    Inventors: XIAOYAN SUN, HAILONG WANG, JIE CHEN, QUN WANG, CHAO GAO, ZHICHENG ZHANG
  • Patent number: 11117956
    Abstract: The present disclosure provides binding proteins (e.g., antibodies or antigen binding fragments thereof) that specifically bind to Klebsiella pneumoniae O1 and induce opsonophagocytic killing of Klebsiella (e.g., Klebsiella pneumoniae). The present disclosure also provides methods of reducing Klebsiella (e.g., Klebsiella pneumoniae) or treating or preventing Klebsiella (e.g., Klebsiella pneumoniae) infection in a subject comprising administering the Klebsiella pneumoniae O1 binding proteins, (e.g., antibodies or antigen-binding fragments thereof) to the subject.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: September 14, 2021
    Assignees: MedImmune, LLC, Humabs BioMed SA
    Inventors: Qun Wang, Charles Stover, Meghan Pennini, Chew-shun Chang, Xiaodong Xiao, Jamese Hilliard, Gilad Kaplan, Davide Corti, Elisabetta Cameroni, Martina Beltramello
  • Publication number: 20210264142
    Abstract: Embodiments of the present disclosure provide an image recognition method and apparatus, an electronic device and a medium, and relates to the field of image processing. The method may include: acquiring a to-be-recognized image sent by a client, and determining whether the to-be-recognized image is a back image; determining characteristic information of the to-be-recognized image in at least one dimension, when it is determined that the to-be-recognized image is the back image; and determining a target front side image matching the to-be-recognized image according to the characteristic information, and returning the target front side image to the client to cause the client to display the target front side image.
    Type: Application
    Filed: September 18, 2020
    Publication date: August 26, 2021
    Inventors: Miao ZHANG, Qun WANG
  • Publication number: 20210238263
    Abstract: The present disclosure provides binding proteins (e.g., antibodies or antigen binding fragments thereof) that specifically bind to Klebsiella pneumoniae O2 and induce opsonophagocytic killing of Klebsiella (e.g., Klebsiella pneumoniae) and/or protects mice from a lethal Klebsiella challenge. The present disclosure also provides methods of reducing Klebsiella (e.g., Klebsiella pneumoniae) or treating or preventing Klebsiella (e.g., Klebsiella pneumoniae) infection in a subject comprising administering the Klebsiella pneumoniae O2 binding proteins, (e.g., antibodies or antigen-binding fragments thereof) to the subject.
    Type: Application
    Filed: August 4, 2017
    Publication date: August 5, 2021
    Inventors: Qun Wang, Charles K. Stover, Meghan Pennini, Xiaodong Xiao, Davide Corti, Elisabetta Cameroni, Martina Beltramello, Gilad KAPLAN, Anna DeMARCO
  • Publication number: 20210192004
    Abstract: The present application provides a method and an apparatus for processing webpage, a device and storage medium, involving the terminal vision technology. The specific implementation is: when a server determines that a current network meets a preset condition and a webpage to be displayed includes an image required to be displayed, the server sends a static data resource corresponding to the image required to be displayed to the terminal. The preset condition includes at least one of the following: the current network being a mobile network, a bandwidth of the current network being less than a preset bandwidth, and a rate of the current network being less than a preset rate. Therefore, it is unnecessary to send a static data resource corresponding to an image not required to be displayed to the terminal, thereby reducing a traffic consumption and at the meanwhile, improving an integrity and coherence of the webpage.
    Type: Application
    Filed: September 14, 2020
    Publication date: June 24, 2021
    Applicant: BAIDU ONLINE NETWORK TECHNOLOGY (BEIJING) CO., LTD.
    Inventors: Qun WANG, Penghe LI
  • Publication number: 20210153764
    Abstract: The present disclosure is directed to systems and methods for generating images using short tau inversion recovery, ultrashort echo time (STIR-UTE) MRI sequences. The STIR-UTE MRI sequences can be used to generate images that can differentiate between regions that are at temperatures that are either lethal or non-lethal to cell life. Thus, these sequences can be beneficial for implementations such as in monitoring cryoablation procedures.
    Type: Application
    Filed: November 18, 2020
    Publication date: May 27, 2021
    Inventors: Junichi Tokuda, Qun Wang, Kemal Tuncali, Ravi Teja Seethamraju, Clare M. Tempany, Ehud J. Schmidt
  • Patent number: 11003931
    Abstract: The present application discloses a vehicle monitoring method and apparatus, processor, and image acquisition device. The method includes: identifying a vehicle window area image in a vehicle image obtained through monitoring; performing feature identification on the vehicle window area image to obtain an identification result of a target feature; performing human eye sensory processing on the vehicle image and the vehicle window area image respectively, and stitching the processed vehicle image and the processed vehicle window area image to obtain a processed image; and outputting the identification result of the target feature and the processed image. The present application solves the technical problem of relatively low identification rate in vehicle monitoring by image detection.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: May 11, 2021
    Assignee: Hangzhou Hikvision Digital Technology Co., Ltd.
    Inventors: Qun Wang, Jun Chen, Jinhong Qi, Binghua Luo
  • Publication number: 20210040153
    Abstract: The present invention relates to the field of virology, and specifically discloses a short peptide having a dengue virus replication inhibition function and an application thereof. The amino acid sequence of the short peptide provided in the present invention is KHGHHRH, i.e. Lys-His-Gly-His-His-Arg-His (SEQ ID NO. 1). The short peptide has a high specificity affinity with NS5 and has the function of efficiently inhibiting dengue virus replication, the anti-viral effect thereof not been limited to DENV-2, but also having a significant inhibitory effect on the replication of type 1, type 3, and type 4 dengue virus. One cysteine is added to the two ends of the short peptide sequence, the short peptide being cyclised by means of the cysteines at the two ends to form a cyclic peptide. The obtained cyclic peptide strengthens the dengue virus replication inhibition function, and can be used for specific treatment of dengue virus infection.
    Type: Application
    Filed: December 28, 2018
    Publication date: February 11, 2021
    Inventors: Minglian Wang, Jinsong Li, Qun Wang, Yishu Yang, Jintao Li, Wei Liu, Xiangqian Xiao, Xiaojin Su
  • Patent number: D919572
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: May 18, 2021
    Assignee: SHENZHEN CARKU TECHNOLOGY CO., LIMITED
    Inventors: Yun Lei, Yidan Hu, Qun Wang
  • Patent number: D952248
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: May 17, 2022
    Assignee: SHENZHEN CARKU TECHNOLOGY CO., LIMITED
    Inventors: Yun Lei, Qun Wang